BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

69 related articles for article (PubMed ID: 2609818)

  • 21. Dendritic reorganisation in the basal forebrain under degenerative conditions and its defects in Alzheimer's disease. I. Dendritic organisation of the normal human basal forebrain.
    Arendt T; Marcova L; Bigl V; Brückner MK
    J Comp Neurol; 1995 Jan; 351(2):169-88. PubMed ID: 7699111
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Measurement of basal forebrain atrophy in Alzheimer's disease using MRI.
    Teipel SJ; Flatz WH; Heinsen H; Bokde AL; Schoenberg SO; Stöckel S; Dietrich O; Reiser MF; Möller HJ; Hampel H
    Brain; 2005 Nov; 128(Pt 11):2626-44. PubMed ID: 16014654
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Topographic relationship between neurofibrillary change and acetylcholinesterase rich neurons in the upper brain stem of patients with senile dementia of the Alzheimer's type and Down's syndrome.
    Shortridge BA; Vogel FS; Burger PC
    Clin Neuropathol; 1985; 4(6):227-37. PubMed ID: 2934202
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Loss of pedunculopontine neurons in progressive supranuclear palsy.
    Zweig RM; Whitehouse PJ; Casanova MF; Walker LC; Jankel WR; Price DL
    Ann Neurol; 1987 Jul; 22(1):18-25. PubMed ID: 3631916
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Morphometry of dorsal raphe nucleus serotonergic neurons in alcoholism.
    Underwood MD; Mann JJ; Arango V
    Alcohol Clin Exp Res; 2007 May; 31(5):837-45. PubMed ID: 17378916
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Diminished aromatase immunoreactivity in the hypothalamus, but not in the basal forebrain nuclei in Alzheimer's disease.
    Ishunina TA; van Beurden D; van der Meulen G; Unmehopa UA; Hol EM; Huitinga I; Swaab DF
    Neurobiol Aging; 2005 Feb; 26(2):173-94. PubMed ID: 15582747
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The neuropathological changes associated with normal brain aging.
    Hof PR; Glannakopoulos P; Bouras C
    Histol Histopathol; 1996 Oct; 11(4):1075-88. PubMed ID: 8930649
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Morphological and quantatitive capillary changes in aging human brain].
    Wang LN; Xu D; Gui QP; Zhu MW; Zhang HH; Hu YZ
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2004 Apr; 26(2):104-7. PubMed ID: 15171542
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The percentage of projection neurons and local circuit neurons in different nuclei of the human thalamus.
    Braak H; Weinel U
    J Hirnforsch; 1985; 26(5):525-30. PubMed ID: 4086805
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Rostrocaudal and ventrodorsal change in neuronal cell size in human medial vestibular nucleus.
    Díaz C; Suárez C; Navarro A; González Del Rey C; Alvarez JC; Méndez E; Tolivia J
    Anat Rec; 1996 Nov; 246(3):403-9. PubMed ID: 8915462
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Morphologic criteria of the structural asymmetry of the cortical and subcortical structures of the human brain].
    Bogolepova IN; Amunts VV; Orzhekhovskaia NS; Malofeeva LI
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1983; 83(7):971-5. PubMed ID: 6624328
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Morphological characteristics of the A10 catecholaminergic group of neurons in the human midbrain.
    Marinković S
    Anat Anz; 1990; 171(2):115-24. PubMed ID: 2260762
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Beta-amyloid cortical deposits are accompanied by the loss of serotonergic neurons in the dog.
    Bernedo V; Insua D; Suárez ML; Santamarina G; Sarasa M; Pesini P
    J Comp Neurol; 2009 Apr; 513(4):417-29. PubMed ID: 19180552
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Quantitative analysis of capillary and neuron images under normal conditions and in dementia].
    Schulz-Dazzi U
    Biull Eksp Biol Med; 1986 Jan; 101(1):102-5. PubMed ID: 3942804
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The evolution of Alzheimer's disease-related cytoskeletal pathology in the human raphe nuclei.
    Rüb U; Del Tredici K; Schultz C; Thal DR; Braak E; Braak H
    Neuropathol Appl Neurobiol; 2000 Dec; 26(6):553-67. PubMed ID: 11123722
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cell loss in the nucleus raphes dorsalis in Alzheimer's disease.
    Aletrino MA; Vogels OJ; Van Domburg PH; Ten Donkelaar HJ
    Neurobiol Aging; 1992; 13(4):461-8. PubMed ID: 1508296
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Thalamic nuclei in Alzheimer disease: evidence against the cholinergic hypothesis of plaque formation.
    Masliah E; Terry R; Buzsáki G
    Brain Res; 1989 Jul; 493(2):240-6. PubMed ID: 2765898
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The human oral raphe system. Architectonics and neuronal types in pigment-Nissl preparations.
    Ohm TG; Heilmann R; Braak H
    Anat Embryol (Berl); 1989; 180(1):37-43. PubMed ID: 2476947
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Alzheimer's disease as a disorder of isodendritic core.
    Benton JS; Bowen DM; Allen SJ; Haan EA; Davison AN; Neary D; Murphy RP; Snowden JS
    Lancet; 1982 Feb; 1(8269):456. PubMed ID: 6121126
    [No Abstract]   [Full Text] [Related]  

  • 40. Neuropathology of psychotic symptoms in Alzheimer's disease.
    Bondareff W
    Int Psychogeriatr; 1996; 8 Suppl 3():233-7; discussion 269-72. PubMed ID: 9154569
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.